| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | | Total Revenue | 923,000 | 1,091,400 | | Cost of Revenue | 472,000 | 616,100 | | | Gross Profit | 451,000 | 475,300 | | | Operating Expenses | | Research Development | 36,000 | 44,800 | | Selling General and Administrative | 297,000 | 283,800 | | Non Recurring | 1,000 | 17,500 | | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 117,000 | 129,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 39,100 | | Earnings Before Interest And Taxes | 75,000 | 168,300 | | Interest Expense |
-
| 19,600 | | Income Before Tax | 75,000 | 148,700 | | Income Tax Expense | 20,000 | 52,500 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 55,000 | 96,200 | | | Non-recurring Events | | Discontinued Operations | 26,000 |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 81,000 | 96,200 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $81,000 | $96,200 |
|
0.31% Nasdaq 
0.05%
Income Statement
